BridgeBio Pharma, Inc. Intellectual Property Contracts & Agreements

7 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Letter Agreement, Amendment #1 thereto, and Amendments to License Agreement between QED Therapeutics, Inc. and Novartis International Pharmaceutical Ltd., dated May 4, 2018,...
License Agreements
BridgeBio Pharma, Inc.
Biotechnology
MA
2024
Fourth Amendment to the Exclusive License Agreement, between The Regents of the University of California and TheRas, Inc., dated December 16, 2019
License Agreements
BridgeBio Pharma, Inc.
Biotechnology
2020
License Agreement, by and between the Registrant and Alexion Pharma International Operations Unlimited Company, dated September 9, 2019
License Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2019
Cell Line License Agreement, by and between Life Technologies Corporation and BridgeBio Services, Inc., effective as of November 15, 2018
License Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2019
Exclusive Patent License Agreement, between The Frederick National Laboratory for Cancer Research, operated by Leidos Biomedical Research, Inc., under sponsorship from the...
License Agreements
BridgeBio Pharma, Inc.
Biotechnology
2019
Exclusive License Agreement, between The Regents of the University of California and TheRas, Inc., dated September 28, 2016, as amended by First Amendment effective January 10,...
License Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2019
License Agreement, between QED Therapeutics, Inc. and Novartis International Pharmaceutical Ltd., dated as of January 29, 2018
License Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2019